Safety and Efficacy Study of Gene Therapy for Acute Myocardial Infarction in Korea
Conditions: Ischemic Heart Disease; Acute Myocardial Infarction Interventions: Biological: Stage 1-Low dose VM202; Biological: Stage 1-Middle dose VM202; Biological: Stage 1-High dose VM202; Drug: Stage 2-Placebo; Biological: Stage 2-Low dose VM202; Biological: Stage 2-High dose VM202; Device: C-Cathez® Catheter Sponsor: ViroMed Co., Ltd. dba VM BioPharma Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials